Cite

HARVARD Citation

    Gligorov, J. et al. (n.d.). P103 Subcutaneous trastuzumab plus chemotherapy for early breast cancer: interim safety from SafeHer. Breast. pp. S60-S61. [Online]. 
  
Back to record